In this section you will find Selcia news and up-coming events Selcia is attending.
News & Events
Read the article in Genetic Engineering and Biotechnology News GEN (15 Feb 2013, Vol. 44 No. 4) on Targeting Protein-Protein Interactions for an overview of some interesting contributions to the field including Selcia's Affinity Capillary Electrophoresis technology.
Selcia Limited, the international life science contract research organisation, has announced the launch of a new platform to enable drug discovery and development on the target family of peptidyl-prolyl cis-trans isomerases ("PPIases").
Simon Saxby, CEO of Selcia Ltd. speaks to EPC about the changes that the pharma industry has faced over the past 12 months and his predictions for 2013.
Selcia Limited, a global leader in 14C radiolabelling and integrated drug discovery service provider, has received GLP re-certification for its analytical laboratory following a successful Good Laboratory Practice (GLP) inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA).
UK-based Mitopharm Limited, a subsidiary of Selcia Holdings Limited, and Swedish drug development company NeuroVive Pharmaceutical AB have developed three lead drug candidates capable of increasing mitochondrial energy production.